Bruce D. Behounek
Profile
Bruce D.
Behounek worked as a Senior Medical Director-Medical Affairs at ICON Clinical Research, Inc. and as a Vice President & Chief Medical Officer at LipoScience, Inc. He completed his undergraduate degree at Cornell University and his doctorate at the University of Maryland.
Former positions of Bruce D. Behounek
| Companies | Position | End |
|---|---|---|
ICON Clinical Research, Inc.
 ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Chief Tech/Sci/R&D Officer | 31/12/2009 |
| LIPOSCIENCE INC | Chief Tech/Sci/R&D Officer | - |
Training of Bruce D. Behounek
| Cornell University | Undergraduate Degree |
| University of Maryland | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
LipoScience, Inc.
 LipoScience, Inc. Medical SpecialtiesHealth Technology LipoScience, Inc. develops and markets medical applications of Nuclear Magnetic Resonance. The firm provides advanced patient care for the patients who are suffering from cardiovascular, metabolic and other related diseases. The company was founded by James D. Otvos, Stephen K. Markham, and Richard A. Franco, Sr. and is headquartered in Raleigh, NC. | Health Technology |
ICON Clinical Research, Inc.
ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Commercial Services |
- Stock Market
- Insiders
- Bruce D. Behounek
